SARS-CoV-2 polymerase

It's only one trial, and we don't even know if the report is correct. But a leaked draft report indicated that remdesivir was ineffective in its first controlled trial. Let's assume that this is true and we see the same from other trials. If so, this will not simply be another experimental drug failing. It will be deeply disturbing. Here's why.
The world anxiously awaits while clinical trials of remdesivir are in progress. The drug failed to stop Ebola. Does this mean it will also fail to stop coronavirus? No. According to a new study in the Journal of Biological Chemistry, the drug should work better. Here's why.